FDA Clearance Tracker · P160001-S020
Obalon Balloon System with Navigation Touch
Last checked: Nov 20, 2026Latest source record: Dec 20, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Dec 20, 2018
Approved
Time to decision
142 days
Received Jul 31, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P160001-S020
- Device name
- Obalon Balloon System with Navigation Touch
- Applicant
- Medtimo, Inc.
- Applicant location
- Eden Prairie, MN
- Received
- Jul 31, 2018
- Decided
- Dec 20, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P160001
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the use of the Obalon Navigation-Touch System for administration of the Obalon Balloon System.
Source documents
Other decisions for Medtimo, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P160001 · Decided Sep 8, 2016 · 245 days after receipt
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.